Comparison of breast and gastric HER2 immunohistochemistry (IHC) scoring criteria in the assessment of endometrial carcinoma

Breast and gastric scoring criteria show high concordance in endometrial carcinoma, with discordance primarily in equivocal tumors. RNA expression may help stratify equivocal from negative cases. Further study is needed to determine whether HER2 alterations at the DNA, RNA, or protein level predict response to newer generation HER2-targeted therapies.

Authors

Institutions

Publication Details

Journal
Gynecologic Oncology
Published
2025-11-16
DOI
https://doi.org/10.1016/j.ygyno.2025.10.034
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparison of breast and gastric HER2 immunohistochemistry (IHC) scoring criteria in the assessment of endometrial carcinoma

Cara Mathews, Matthew J. Oliver, Shuanzeng Wei, Andrew Elliott et al.
Gynecologic Oncology
HER2/EGFR in Cancer Research
article

Comparison of breast and gastric HER2 immunohistochemistry (IHC) scoring criteria in the assessment of endometrial carcinoma

Cara Mathews, Matthew J. Oliver, Shuanzeng Wei, Andrew Elliott, Premal H. Thaker, Jaclyn F. Hechtman, Harris B. Krause, Whitney R. Grither, Matthew James Oberley, Sharon Wu, Rouba-Ali Fehmi, Rachel L Furuya, Matthew A. Powell, Katherine E. Miller, Mark G. Evans, David A. Bryant
article en

Abstract

Breast and gastric scoring criteria show high concordance in endometrial carcinoma, with discordance primarily in equivocal tumors. RNA expression may help stratify equivocal from negative cases. Further study is needed to determine whether HER2 alterations at the DNA, RNA, or protein level predict response to newer generation HER2-targeted therapies.

Gynecologic OncologyVol. 204
Fox Chase Cancer Center (US), Washington University in St. Louis (US), Brown University (US), University of Michigan (US), Temple University Health System (US), Caris Life Sciences (United States) (US)
Openalex Percentile: Top 53%
HER2/EGFR in Cancer Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.